1st Quarter - Report

PUBLIC CITIZEN for PUBLIC CITIZEN

Firm
Client
Income
—
Expenses
$60,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

13 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

NAFTA, NAFTA renegotiation,

LobbyistCovered position, as disclosed
LORI WALLACH —

Contacted: Securities & Exchange Commission (SEC); Labor, Dept of (DOL); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; SENATE

Banking BAN

S 2155-Economic Growth Regulatory Relief and Consumer Protection Act, HR 1264-Community Financial Institutions Exemption Act, HR 1426-Federal Savings Association Charter Flexibility Act of 2017, HR 2226-Portfolio Lending and Mortgage Access Act, HR 3299-Protecting Consumer Access to Credit Act of 2017, HR 2978-Voting Rights Advancement Act of 2017, HR 4296-Place requirements on operational risk capital requirements for banking organizations established by appropriate federal banking agency, HR 1116-TAILOR Act, HR 4061-Financial Stability Oversight Council Improvement Act of 2017, HR 4263-Regulatory A+ Improvement Act of 2017, HR 4545-Financial Institutions Examination Fairness and Reform Act, HR 4293-STRESS Test Improvement Act of 2017, HR 4566-Alleviating Stress Test burdens to help investors act, Anti-trust remedies, Fighting the Crapo bank deregulatory bill,

LobbyistCovered position, as disclosed
LISA JEAN GILBERT —
BARTLETT NAYLOR —

Contacted: Labor, Dept of (DOL); Securities & Exchange Commission (SEC); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3299 (115th), H.R. 4293 (115th), H.R. 2226 (115th), H.R. 4545 (115th), H.R. 1116 (115th), H.R. 4566 (115th), H.R. 1264 (115th), H.R. 2978 (115th), H.R. 4296 (115th), H.R. 4061 (115th), H.R. 4263 (115th), H.R. 1426 (115th)

Civil Rights/Civil Liberties CIV

#Metoo legislation as connected to employment forced arbitration clauses, SEC issues, METOO issues, reforming procedures for reporting discrimination and harassment, sexual harassment reforms, arbitration, civil justice issues,

LobbyistCovered position, as disclosed
LISA JEAN GILBERT —
REMINGTON GREGG —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; U.S. Trade Representative (USTR); Securities & Exchange Commission (SEC); Labor, Dept of (DOL)

Agriculture AGR

Infrastructure discussion and impact on rural areas

LobbyistCovered position, as disclosed
SUSAN ELAINE HARLEY —

Contacted: Securities & Exchange Commission (SEC); U.S. Trade Representative (USTR); SENATE; HOUSE OF REPRESENTATIVES; Labor, Dept of (DOL)

Consumer Issues/Safety/Products CSP

Regulatory reform, S 2296-Guidance out of Darkness Act

LobbyistCovered position, as disclosed
AMIT NARANG —

Contacted: U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Securities & Exchange Commission (SEC); Labor, Dept of (DOL); SENATE

Government Issues GOV

Inaugural Funds accountability, S 625-Foreign Agents Registration Modernization and Enforcement Act, Congressional earmarking, Strengthen Office of Government Ethics, S 2039, HR 4170- Disclosing Foreign Influence Act, Protect the Russia/Trump investigation, support a broad democracy package,

LobbyistCovered position, as disclosed
LISA JEAN GILBERT —
CRAIG HOLMAN —

Contacted: Securities & Exchange Commission (SEC); SENATE; Labor, Dept of (DOL); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR)

Bills named: H.R. 4170 (115th)

Health Issues HCR

Single Payer Health Care, Right to Try/False Hope, drug pricing

LobbyistCovered position, as disclosed
LISA JEAN GILBERT —
EAGAN KEMP —

Contacted: SENATE; Labor, Dept of (DOL); HOUSE OF REPRESENTATIVES; Securities & Exchange Commission (SEC); U.S. Trade Representative (USTR)

Budget/Appropriations BUD

Keep the budget free from poison pill riders, CPC People's budget,

LobbyistCovered position, as disclosed
LISA JEAN GILBERT —
SUSAN ELAINE HARLEY —

Contacted: Labor, Dept of (DOL); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Securities & Exchange Commission (SEC); SENATE

Transportation TRA

Infrastructure investments

LobbyistCovered position, as disclosed
SUSAN ELAINE HARLEY —

Contacted: Labor, Dept of (DOL); SENATE; U.S. Trade Representative (USTR); Securities & Exchange Commission (SEC); HOUSE OF REPRESENTATIVES

Labor Issues/Antitrust/Workplace LBR

Congressional sexual harassment & whistleblower reform, S 2159/HR 4396-ME TOO Congress Act, workplace safety legislation, DOL tip pooling proposal,

LobbyistCovered position, as disclosed
SHANNA DEVINE —

Contacted: SENATE; Securities & Exchange Commission (SEC); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Labor, Dept of (DOL)

Bills named: H.R. 4396 (115th)

Taxation/Internal Revenue Code TAX

Oppose Johnson Amendment riders, Support Bright Lines Project Legislation, Wall Street Speculation Tax/Financial Transaction tax, No tax breaks for outsourcing Act

LobbyistCovered position, as disclosed
SUSAN ELAINE HARLEY —
EMILY PETERSON CASSIN —

Contacted: U.S. Trade Representative (USTR); Securities & Exchange Commission (SEC); HOUSE OF REPRESENTATIVES; SENATE; Labor, Dept of (DOL)

Financial Institutions/Investments/Securities FIN

Opposing the Crapo financial deregulation bill, Supporting Dodd-Frank executive pay regulations

LobbyistCovered position, as disclosed
LISA JEAN GILBERT —

Contacted: Labor, Dept of (DOL); U.S. Trade Representative (USTR); Securities & Exchange Commission (SEC); HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

S. 771/HR 1776-Improving access to affordable Prescription Drugs act, S 2157-Drug Price transparency in Communications Act, S 2011/HR 4138-Medicare drug price negotiation act of 2017, S 1688-Empowering medicare seniors to negotiate drug prices of 2017, S 252-Medicare drug savings act of 2017, S 1369/HR 2974-Stop Price gouging act, S 124-Preserve access to affordable generics act, S 974/HR 2212-CREATES Act of 2017, S 495-Medical Innovation and Prize Fund Act, S 1131/HR 2439-FAIR drug pricing act, Over-the-counter Monograph Safety, Innovation, and Reform Act of 2018, HR 4117-Competitive DRUGS Act of 2017), HR 2051- FAST Generics Act of 2017), Prescription drug pricing, PACED Act, S 771/HR 1776 (Improving access to affordable prescription drugs act, S 1509/HR 1223 OPEN Act), S 1309-Stronger patents act, HR 5150 Protecting Medicare from excessive price increases act, S 2476-Expanding access to low cost generics act, S 637 (c-thru act), S 1348-SPIKE act,

LobbyistCovered position, as disclosed
STEVEN KNIEVEL —

Contacted: U.S. Trade Representative (USTR); Securities & Exchange Commission (SEC); SENATE; HOUSE OF REPRESENTATIVES; Labor, Dept of (DOL)

Bills named: H.R. 1776 (115th), H.R. 2212 (115th), H.R. 2439 (115th), S. 771 (115th), H.R. 5150 (115th), H.R. 4117 (115th), H.R. 4138 (115th), H.R. 2051 (115th), H.R. 1223 (115th), H.R. 2974 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.